Sunday, January 11, 2004 12:54:07 PM
DNAPrint and Orchid Announce Option Agreement
On October 24, 2000, DNAPrint genomics announced an Option agreement with Orchid Biosciences (NASD:ORCH) of Princeton NJ, a leader in high-throughput genotyping. Under the terms of the agreement, Orchid provided DNAPrint an up-front payment for the option to negotiate exclusively for a license to co-develop and/or co-commercialize certain DNAPrint products in the future. The agreement provides DNAPrint with a potential distribution channel and applies to products the company is currently developing, and will develop in the near future.
News Release - October 24, 2000
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM